Simplex Trading
CTXR icon

Simplex Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Simplex Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,556
Closed -$11K – 8811
2025
Q3 		$11K Buy
+9,556
New +$13.3K ﹤0.01% 7803
2025
Q2 		– Sell
-966
Closed -$1K – 8806
2025
Q1 		$1K Sell
966
-754
-44% -$1.8K ﹤0.01% 8179
2024
Q4 		$6K Buy
1,720
+1,378
+403% +$9.28K ﹤0.01% 7487
2024
Q3 		$4K Sell
342
-84
-20% -$1.41K ﹤0.01% 7695
2024
Q2 		$6K Buy
426
+137
+47% +$2.46K ﹤0.01% 7741
2024
Q1 		$6K Sell
289
-1,391
-83% -$25.4K ﹤0.01% 7898
2023
Q4 		$31K Buy
1,680
+597
+55% +$11.3K ﹤0.01% 6528
2023
Q3 		$18K Buy
+1,083
New +$25.7K ﹤0.01% 6699
2022
Q3 		– Sell
-1,694
Closed -$46.6K – 10040
2022
Q2 		$38K Buy
1,694
+1,068
+171% +$29.3K ﹤0.01% 6841
2022
Q1 		$28K Buy
626
+594
+1,856% +$23.5K ﹤0.01% 7837
2021
Q4 		$1K Sell
32
-924
-97% -$41.9K ﹤0.01% 10162
2021
Q3 		$62K Buy
+956
New +$48K ﹤0.01% 7258

Other funds holding CTXR

HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Simplex Trading's CTXR Position: Q4 2025 in Review

Simplex Trading sold out of Citius Pharmaceuticals (CTXR) in Q4 2025, closing a stake of 9,556 shares — an estimated $11K sold.

Simplex Trading first reported a position in CTXR in Q3 2021 and held it in 12 quarters. The position peaked at $62K in Q3 2021. 39 funds tracked by Wall St. Rank hold CTXR as of Q4 2025.

  • Simplex Trading reported no remaining Citius Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 9,556 Citius Pharmaceuticals shares in Q4 2025, an estimated $11K.
  • Simplex Trading first reported a position in Citius Pharmaceuticals in Q3 2021 and held it in 12 quarters.
  • Simplex Trading's Citius Pharmaceuticals position peaked at $62K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.